Gleason Group, Inc. Viatris Inc Transaction History
Gleason Group, Inc.
- $546 Million
- Q3 2024
A detailed history of Gleason Group, Inc. transactions in Viatris Inc stock. As of the latest transaction made, Gleason Group, Inc. holds 34 shares of VTRS stock, worth $442. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34
Previous 830
95.9%
Holding current value
$442
Previous $8,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding VTRS
# of Institutions
1,091Shares Held
924MCall Options Held
2.44MPut Options Held
2.15M-
Vanguard Group Inc Valley Forge, PA141MShares$1.83 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$1.2 Billion0.02% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az62.6MShares$814 Million4.18% of portfolio
-
State Street Corp Boston, MA62.1MShares$807 Million0.03% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD56.8MShares$739 Million0.07% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $15.8B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...